Pereira J, Cavaco P, da Silva R, Pacheco Leyva I, Mereiter S, Pinto R, et al. P-selectin glycoprotein ligand 1 promotes T cell lymphoma development and dissemination. Transl Oncol. 2021;14:101125 pubmed publisher

Siepe D, Henneberg L, Wilson S, Hess G, Bassik M, Zinn K, et al. Identification of orphan ligand-receptor relationships using a cell-based CRISPRa enrichment screening platform. elife. 2022;11: pubmed publisher

Ahmed R, Ananth K, Omidian Z, Majety N, Zhang H, Hamad A. Detection, sorting, and immortalization of dual expresser lymphocytes from human peripheral blood samples. STAR Protoc. 2021;2:100925 pubmed publisher

Japp A, Meng W, Rosenfeld A, Perry D, Thirawatananond P, Bacher R, et al. TCR+/BCR+ dual-expressing cells and their associated public BCR clonotype are not enriched in type 1 diabetes. Cell. 2021;184:827-839.e14 pubmed publisher

Bourges C, Groff A, Burren O, Gerhardinger C, Mattioli K, Hutchinson A, et al. Resolving mechanisms of immune-mediated disease in primary CD4 T cells. EMBO Mol Med. 2020;12:e12112 pubmed publisher

Lu Y, Zhao Q, Liao J, Song E, Xia Q, Pan J, et al. Complement Signals Determine Opposite Effects of B Cells in Chemotherapy-Induced Immunity. Cell. 2020;180:1081-1097.e24 pubmed publisher

Sun B, Yang D, Dai H, Liu X, Jia R, Cui X, et al. Eradication of Hepatocellular Carcinoma by NKG2D-Based CAR-T Cells. Cancer Immunol Res. 2019;7:1813-1823 pubmed publisher

Ahmed R, Omidian Z, Giwa A, Cornwell B, Majety N, Bell D, et al. A Public BCR Present in a Unique Dual-Receptor-Expressing Lymphocyte from Type 1 Diabetes Patients Encodes a Potent T Cell Autoantigen. Cell. 2019;177:1583-1599.e16 pubmed publisher